ArticleThe Lancet. Infectious diseases2020
Long-term consequences of COVID-19: research needs.
Abstract readComment
In one paragraph
Article in The Lancet. Infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 172 papers, 5 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed, 5 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
172 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Associated thromboembolic events to the post COVID syndrome: a systematic review and meta-analysis.Frontiers in cardiovascular medicine · 2026Pooled it
- Pooled it
- Monitoring Symptoms of COVID-19: Review of Mobile Apps.JMIR mHealth and uHealth · 2022Pooled it
- Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology.Medicina (Kaunas, Lithuania) · 2021Pooled it
- Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data.Frontiers in medicine · 2021Pooled it
- Azvudine reduces the in-hospital mortality of COVID-19 patients: A retrospective cohort study.Acta pharmaceutica Sinica. B · 2023Trial
- Hyperbaric Oxygen Therapy on Long COVID Symptoms: A Breath of Fresh Air.Diseases (Basel, Switzerland) · 2026Review
- Effect of combined training on the cardiorespiratory, muscle system and body composition in employees at a tertiary hospital after mild to moderate intensity COVID 19.Clinics (Sao Paulo, Brazil) · 2025Article
- Neurological, psychological, psychosocial complications of long-COVID and their management.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025Review
- Is there a rationale for hyperbaric oxygen therapy in the patients with Post COVID syndrome? : A critical review.European archives of psychiatry and clinical neuroscience · 2024Review
- The risk factors for long term cardiovascular symptoms in patients after coronavirus disease 2019 infection.Annals of medicine · 2024Observational
- A prospective non-randomized controlled trial testing the effectiveness of psychotherapeutic inpatient treatment of Post-COVID-19 syndrome - study protocol.BMC psychology · 2024Article
- Radiotracers for Molecular Imaging of Angiotensin-Converting Enzyme 2.International journal of molecular sciences · 2024Review
- Study of Postacute Sequelae of COVID-19 Using Digital Wearables: Protocol for a Prospective Longitudinal Observational Study.JMIR research protocols · 2024Observational
- The Significance of Endothelial Dysfunction in Long COVID-19 for the Possible Future Pandemic of Chronic Kidney Disease and Cardiovascular Disease.Biomolecules · 2024Review
- Hospital Mortality and Morbidity in Diabetic Patients with COVID-19: A Retrospective Analysis from the UAE.International journal of environmental research and public health · 2024Article
- ERS International Congress 2023: highlights from the Respiratory Clinical Care and Physiology Assembly.ERJ open research · 2024Article
- Vascular Alterations Following COVID-19 Infection: A Comprehensive Literature Review.Life (Basel, Switzerland) · 2024Review
- Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID.NPJ science of food · 2024Review
- Pain types and risk factors in post-COVID-19.Turkish journal of physical medicine and rehabilitation · 2024Article
112 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Comment on
Authors and funding
15 authors.
Dana YelinUnit of infectious Diseases, Beilinson Hospital, Rabin Medical Center, Petah-Tiqva 49100, Israel.
Eytan WirtheimManagement, Beilinson Hospital, Rabin Medical Center, Petah-Tiqva 49100, Israel.
Pauline VetterGeneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland; Laboratory of Virology, Division of Infectious Diseases, Division of Laboratory Medicine, University Hospitals of Geneva and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Andre C KalilDivision of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
Judith BruchfeldDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; Karolinska University Hospital, Stockholm, Sweden; Divison of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Michael RunoldDepartment of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.
Giovanni GuaraldiDepartment of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Cristina MussiniDepartment of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.
Carlota GudiolDepartment of Infectious Diseases, Hospital Universitari de Bellvitge, Institut Investigacions Biomèdiques de Bellvitge, University of Barcelona, Barcelona, Spain.
Miquel PujolDepartment of Infectious Diseases, Hospital Universitari de Bellvitge, Institut Investigacions Biomèdiques de Bellvitge, University of Barcelona, Barcelona, Spain.
Alessandra BanderaClinic of Infectious Diseases, IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano Foundation, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Luigia ScudellerScientific Direction, IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano Foundation, Milan, Italy.
Mical PaulInfectious Diseases Institute, Rambam Health Care Campus and The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
Laurent KaiserGeneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland; Laboratory of Virology, Division of Infectious Diseases, Division of Laboratory Medicine, University Hospitals of Geneva and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Leonard LeiboviciResearch Authority, Beilinson Hospital, Rabin Medical Center, Petah-Tiqva 49100, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. Electronic address: leibovic@post.tau.ac.il.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
BetacoronavirusPandemicsPneumonia, ViralClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingHumansPrognosisSARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.